Tens of thousands of patients with attention deficit hyperactivity disorder nationwide could face disruptions to their care after two executives of a major telehealth company that distributed A.D.H.D.
The Department of Justice announced on Thursday that the chief executive and the clinical president of Done, the telehealth company, had been arrested and accused of participating in a scheme to distribute Adderall and other stimulants for A.D.H.D.
to patients who did not need the medications, and to bill insurers for these drugs.
The charges come amid ongoing shortages of Adderall and another stimulant, Vyvanse.
said that as many as 50,000 patients across the nation who rely on Done or similar telehealth platforms to obtain stimulant medications may be affected.
Persons:
General Merrick B, Garland
Organizations:
of Justice, Centers for Disease Control